The State of Texas Top Legal Officer Takes Legal Action Against Tylenol Producers Concerning Autism Spectrum Assertions

Legal Action
Ken Paxton, a Trump ally seeking election to the United States Senate, accused the drug companies of concealing potential dangers of Tylenol

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, claiming the corporations hid alleged dangers that the pain reliever posed to pediatric cognitive development.

The lawsuit follows thirty days after President Donald Trump promoted an unproven link between taking acetaminophen - alternatively called paracetamol - throughout gestation and autism in young ones.

Paxton is suing J&J, which once produced the medication, the exclusive pain medication approved for pregnant women, and Kenvue, which currently produces it.

In a statement, he said they "misled consumers by profiting off of discomfort and pushing pills regardless of the risks."

Kenvue asserts there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These corporations lied for decades, knowingly endangering countless individuals to increase profits," the attorney general, from the Republican party, said.

The company commented that it was "very worried by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the well-being of US mothers and children."

On its official site, the company also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that indicates a verified association between consuming paracetamol and autism."

Groups representing physicians and health professionals concur.

ACOG has said paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to treat discomfort and fever, which can pose major wellness concerns if left untreated.

"In more than two decades of investigation on the utilization of acetaminophen in gestation, zero credible investigations has conclusively proven that the consumption of paracetamol in any stage of gestation leads to brain development issues in offspring," the organization stated.

The lawsuit cites latest statements from the previous government in arguing the drug is potentially dangerous.

Last month, the former president raised alarms from health experts when he advised expectant mothers to "fight like hell" not to consume Tylenol when sick.

Federal regulators then released a statement that doctors should contemplate reducing the use of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in April to initiate "a massive testing and research effort" that would identify the origin of autism in a matter of months.

But experts warned that identifying a sole reason of autism - thought by researchers to be the outcome of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that influences how individuals encounter and relate to the environment, and is identified using doctors' observations.

In his court filing, the attorney general - who supports Trump who is campaigning for federal office - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the science" around paracetamol and autism.

The case seeks to make the companies "destroy any commercial messaging" that states Tylenol is reliable for pregnant women.

The Texas lawsuit mirrors the complaints of a collection of mothers and fathers of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in two years ago.

Judicial authorities threw out the case, declaring studies from the plaintiffs' authorities was lacking definitive proof.

Kristen Sutton
Kristen Sutton

Lena is a seasoned journalist with a passion for storytelling and uncovering the truth behind the headlines.